GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,633.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 1,671.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,064.03m
  • Volume: 4,218,060
  • Market Cap: £66,366m
  • RiskGrade: 129

Latest ShareCast News

GSK shingles vaccine approved for expanded use in China

By Benjamin Chiou

Date: Tuesday 14 Oct 2025

(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.

London midday: UK stocks keep grinding towards year's highs

By Alexander Bueso

Date: Friday 03 Oct 2025

(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the ongoing budget standoff in Washington D.C..

Emma Walmsley to step down as chief executive of GSK

By Abigail Townsend

Date: Monday 29 Sep 2025

(Sharecast News) - Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role.

Trump to impose tariffs of 100% on branded drug ... 26-Sep-2025 ShareCast
GSK plans $30bn US investment as pharma faces ta... 17-Sep-2025 ShareCast
GSK gepotidacin edges closer to landmark approva... 11-Aug-2025 ShareCast
GSK and CureVac secure $740m payout in mRNA pate... 08-Aug-2025 ShareCast
London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
GSK and Hengrui unveil development deal worth up... 28-Jul-2025 ShareCast
London close: FTSE finishes week just shy of 9,000 18-Jul-2025 ShareCast
FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast
US FDA approves new format of GSK's Shingrix 17-Jul-2025 ShareCast
US FDA to review GSK bid to extend use of respir... 14-Jul-2025 ShareCast
EMA accepts marketing authorisation application ... 23-Jun-2025 ShareCast
GSK hoping to expand Arexvy usage in Japan 20-Jun-2025 ShareCast
GSK's RSV vaccine accepted for regulatory review... 13-Jun-2025 ShareCast
Berenberg downgrades GSK to 'hold' ahead of prod... 03-Jun-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,633.00p
Change Today 5.00p
% Change 0.31 %
52 Week High 1,671.50p
52 Week Low 1,264.00p
Volume 4,218,060
Shares Issued 4,064.03m
Market Cap £66,366m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Emma Walmsley

Top of Page